Breast CT developer Koning has raised over $2.6 million in its first crowdfunding campaign.
Conducted on crowdfunding platform Republic, the campaign was completed in five months and exceeded the firm's capital targets, Koning said.
In other news, a trial is now underway to assess the company's breast CT scanner in screening applications. Clinics in Daytona Beach, FL, and Knoxville, TN, are currently participating in the trial, which will be used to support a submission to the U.S. Food and Drug Administration for use of the technology in screening applications.
Koning also reported that it should be ready to begin accepting new installation requests for systems in the latter part of 2022. In addition, several new contracts are underway for devices that are expected to be deployed in major U.S. cities in the second and third quarters of 2022, according to the firm.
